Talk Evidence - isolation periods, openness, and environmental impacts
In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate.
Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.
Finally, the impacts of climate change were set out in a WH...
Source: The BMJ Podcast - January 28, 2022 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - isolation periods, openness, and environmental impacts
In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate.
Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.
Finally, the impacts of climate change were set out in a WH...
Source: The BMJ Podcast - January 28, 2022 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more
Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 25, 2022 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 25, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
TWiV 854: Omicron is evasive
TWiV reviews findings that increased fitness of the Omicron variant is due to immune evasion, not an increase in intrinsic transmissibility, and determination of infectious viral load in patients infected with wild type, Delta and Omicron viruses reveals lack of correlation with RNA loads determined by RT-PCR, similar levels of shedding among Delta and Omicron, and greatly reduced shedding in vaccinated people. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Travel Awa...
Source: This Week in Virology - MP3 Edition - January 16, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 853: COVID-19 clinical update #97 with Dr. Daniel Griffin
In COVID-19 clinical update #97, Daniel Griffin covers immunity after infection recognized by CDC, outcomes before and after Omicron, infectious viral load in Delta vs Omicron, PCR vs rapid antigen tests, booster interval shortened to 5 months, risk factors for severe outcomes in vaccinated, cross-reactive memory T cells, vaccine effectiveness vs MIS-C, and Rivaroxiban for thromboprophylaxis. Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Quarantine and isolation (CDC) Outcomes before and after Omicron (medRxiv) Infectious viral load in Delta vs Omicron infecti...
Source: This Week in Virology - MP3 Edition - January 15, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
COVID-19 CDC Update – Early January 2022
Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the pandemic from a global perspective. Recorded January 6, 2022. Related Content: One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality COVID-19 Vaccines Have Been Available in the US for More Than a Year—What’s Been Learned and What’s Next? COVID-19 CDC Update – Early January 2022 (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 11, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronapod: Omicron - your questions answered
Several weeks after the Omicron variant was first identified, it has quickly spread across the world. Early data are showing clear signals that the latest variant of concern is able to evade immunity and spread at a rate faster than any other variant to date. But many questions remain unanswered about the severity of infection, the protection afforded by natural and vaccine-derived immunity, and the impact Omicron could have on the global pandemic response. In this episode, we delve into the very latest studies to take stock of where we are so far and, in a Coronapod first, take on questions sent in by ...
Source: Nature Podcast - December 17, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: vaccines and long COVID, how protected are you?
Vaccines significantly reduce the risk of developing COVID-19, but scientists are now asking what effect the vaccines might have on long COVID. Long COVID is a somewhat ill-defined, but common, syndrome that can arise from even mild cases of COVID19 - with symptoms ranging from chronic fatigue to breathing difficulties and even neurological deficiency. But little is known about what triggers long COVID, or how to prevent it. As public health experts consider protection measures, the role of vaccines in protecting against long COVID is poorly understood, and although numerous studies are seeking answers, they are turning up...
Source: Nature Podcast - December 10, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: How has COVID impacted mental health?
Studying mental health in populations is not a simple task, but as the pandemic has continued, mounting concerns have mobilised researchers.Now, researchers have used data from helplines in 20 countries to assess the impacts that COVID, as well as associated political and public health measures like financial assistance programs and lockdowns, have had on mental health. Contrary to expectations, loneliness and concerns about the impacts of the pandemic drove most of the callers, rather than imminent threats such as suicidal thoughts or abuse.News: Millions of helpline calls reveal how COVID affected mental healthOmicr...
Source: Nature Podcast - December 3, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: new hope from COVID antiviral drugs
Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick thro...
Source: Nature Podcast - November 12, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
China ’s COVID vaccines have been crucial — now immunity is waning
More that 3 billions doses of China's CoronaVac and Sinopharm vaccines have been administered across the globe, playing an especially important role in Latin America and South East Asia, as well as China. These vaccines use inactivated virus particles to expose the immune system to Sars-CoV-2, but they do not appear to generate the same levels of neutralising antibodies as other vaccine platforms such as those based on mRNA. Now studies are suggesting that this protection may be waning more quickly than with other vaccines, which has sparked a conundrum - in many countries the only vaccines available are CoronaVac or Sinop...
Source: Nature Podcast - October 29, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: can scientists harness COVID super-immunity?
People that have recovered from COVID are seeing stronger immune responses after vaccination than those that never contracted the virus. Researchers are now racing to unpick what is behind this powerful 'hybrid immunity'. In this episode of Coronapod, we discuss a series of studies which are offering up some possibile explanations, and ask how this might inform publish health policy in the future. News: COVID super-immunity: one of the pandemic’s great puzzlesSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. See acast.com/priv...
Source: Nature Podcast - October 25, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Covid in south Asia - India and Nepal
In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health.
In this first podcast, we're focussing on India and Nepal, and are joined by;
Srinath Reddy, president of the Public Health Foundation of India.
Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic
and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal.
For mor...
Source: The BMJ Podcast - October 17, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Do we need booster shots?
Vaccine-rich countries are beginning programmes of COVID-19 vaccine booster shots, but what's the evidence for them? What does this mean for countries which have no vaccines? Prof. Sir Richard Peto and Prof. K. Srinath Reddy discuss. (Source: Listen to The Lancet)
Source: Listen to The Lancet - October 7, 2021 Category: General Medicine Authors: The Lancet Source Type: podcasts
Talk Evidence - testing for respiratory tract infections, cannabis for pain, & covid outcomes
This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence.
On this week’s episode.
As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care
Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and...
Source: The BMJ Podcast - September 29, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
